Systemic Lupus Erythematosus

Ustekinumab Effective in Phase 2 Study for Systemic Lupus Erythematosus

Ustekinumab Effective in Phase 2 Study for Systemic Lupus Erythematosus

By

Results from a phase 2 study suggest that ustekinumab might be an effective therapy in systemic lupus erythematosus.

Improving Medication Adherence With Drug Monitoring in SLE

Improving Medication Adherence With Drug Monitoring in SLE

By

Therapeutic drug monitoring may be useful to help clinicians assess nonadherence in patients with SLE.

Rheumatic Disease Risk Increased in Myasthenia Gravis After Thymectomy

Rheumatic Disease Risk Increased in Myasthenia Gravis After Thymectomy

By

Data revealed an association between myasthenia gravis and autoimmune rheumatic diseases.

Infectious, Noninfectious Postoperative Complications More Frequent in Patients With SLE

Infectious, Noninfectious Postoperative Complications More Frequent in Patients With SLE

By

Patients with systemic lupus erythematosus have a high risk for postoperative complications and mortality following major surgery compared with patients without SLE.

Statin Initiation Reduces Overall Mortality in Systemic Autoimmune Rheumatic Diseases

Statin Initiation Reduces Overall Mortality in Systemic Autoimmune Rheumatic Diseases

By

The initiation of statin therapy is associated with reduced overall mortality in patients with systemic autoimmune rheumatic diseases.

Patient-Reported Outcomes Predict Mortality in Systemic Lupus Erythematosus

Patient-Reported Outcomes Predict Mortality in Systemic Lupus Erythematosus

By

Patient-reported outcomes are independent predictors of mortality in systemic lupus erythematosus.

Improving Rates of Combination Pneumococcal Vaccination in Patients With SLE

Improving Rates of Combination Pneumococcal Vaccination in Patients With SLE

By

Vaccination rates in patients with systemic lupus erythematosus improved significantly after the implementation of a multifaceted intervention at a rheumatology practice.

Tacrolimus Possibly Beneficial Long Term in Lupus Nephritis

Tacrolimus Possibly Beneficial Long Term in Lupus Nephritis

By

Over a 5-year period, the drug was well tolerated and associated with significant declines in urinary protein-creatinine ratio and mean prednisolone dose.

Childhood-Onset Systemic Lupus Erythematosus Negatively Affects Quality of Life in Adulthood

Childhood-Onset Systemic Lupus Erythematosus Negatively Affects Quality of Life in Adulthood

By

Childhood-onset SLE has major effects on quality of life in adulthood.

 Active SLE Disease Activity, Damage Linked to Greater Mortality

Active SLE Disease Activity, Damage Linked to Greater Mortality

By

The use of validated disease activity and damage metrics is important in the assessment of SLE.

Effects of Cigarette Smoking, Alcohol Consumption on SLE Risk in Black Women

Effects of Cigarette Smoking, Alcohol Consumption on SLE Risk in Black Women

By

Cigarette smoking was associated with an increased SLE risk and alcohol consumption was associated with decreased SLE risk.

Prolonged Antimalarial Exposure Increases Risk for Elevated Cardiac Biomarkers in SLE

Prolonged Antimalarial Exposure Increases Risk for Elevated Cardiac Biomarkers in SLE

By

Prolonged antimalarial therapy and persistent creatine phosphokinase elevation resulted in an increased risk for abnormal brain natriuretic peptide and cardiac troponin.

Are Adverse Pregnancy Outcomes Associated With Accelerated Cardiovascular Events in SLE?

Are Adverse Pregnancy Outcomes Associated With Accelerated Cardiovascular Events in SLE?

By

The risk factors for accelerated cardiovascular disease among young women with SLE remain unclear, with multiple studies producing conflicting results.

High Rate of Subclinical Myocardial Injury in Systemic Lupus Erythematosus

High Rate of Subclinical Myocardial Injury in Systemic Lupus Erythematosus

By

Patients with systemic lupus erythematosus have a high prevalence of subclinical myocardial injury, as evidenced by raised high-sensitive troponin levels.

Characteristics of Early-Onset SLE Distinguished From Mimicking Conditions

Characteristics of Early-Onset SLE Distinguished From Mimicking Conditions

By

Patients with early SLE had higher rates of unexplained fever than those with SLE-mimicking conditions.

Lupus Nephritis With Impaired Renal Function Linked to Atherosclerosis in SLE

Lupus Nephritis With Impaired Renal Function Linked to Atherosclerosis in SLE

By

Lupus nephritis in combination with impaired renal function is strongly associated with the presence of atherosclerosis in patients with systemic lupus erythematosus.

Outcomes of SLE-Associated Thrombotic Microangiopathy With Acquired ADAMTS13 Deficiency

Outcomes of SLE-Associated Thrombotic Microangiopathy With Acquired ADAMTS13 Deficiency

By

Researchers investigated the characteristics and outcomes of patients with systemic lupus erythematosus-associated thrombotic microangiopathy based on their ADAMTS13 inhibitor profiles.

High Risk for Zoster in Cyclophosphamide-Treated SLE, Systemic Vasculitis

High Risk for Zoster in Cyclophosphamide-Treated SLE, Systemic Vasculitis

By

The incidence of zoster is high in systemic vasculitis and in patients with SLE exposed to intravenous cyclophosphamide.

Epidemiology, Clinical Characteristics of Systemic Sclerosis vs SSc-SLE Overlap Syndrome

Epidemiology, Clinical Characteristics of Systemic Sclerosis vs SSc-SLE Overlap Syndrome

By

Patients with SSc-SLE overlap syndrome were younger at diagnosis, had higher rates of pulmonary arterial hypertension, and less frequently had SSc cutaneous manifestations.

Depression Risk High in Cutaneous, Systemic Lupus Erythematosus

Depression Risk High in Cutaneous, Systemic Lupus Erythematosus

By

The risk for depression was increased significantly in patients with systemic lupus erythematosus and cutaneous lupus erythematosus.

Silent Cardiac Impairment May Be Present in New-Onset, Drug-Naive Systemic Lupus Erythematosus

Silent Cardiac Impairment May Be Present in New-Onset, Drug-Naive Systemic Lupus Erythematosus

By

Data indicate that drug-naive new onset systemic lupus erythematosus was likely to involve silent cardiac impairment.

Poor Preconceptional Cardiovascular Health Affects Pregnancy Outcomes in SLE

Poor Preconceptional Cardiovascular Health Affects Pregnancy Outcomes in SLE

By

Poor preconception cardiovascular health affects pregnancy outcomes in women with SLE.

Burden of Entheseal Sonographic Changes High in Patients With SLE

Burden of Entheseal Sonographic Changes High in Patients With SLE

By

The burden of entheseal sonographic changes was significantly higher in patients with SLE vs healthy participants, especially with respect to active inflammation.

Corticosteroid Use Linked to Risk for Osteonecrosis in Systemic Lupus Erythematosus

Corticosteroid Use Linked to Risk for Osteonecrosis in Systemic Lupus Erythematosus

By

Investigators sought to identify the risk factors for osteonecrosis and to identify the minimal investigations needed to monitor the risk for osteonecrosis in patients with systemic lupus erythematosus.

Patient-Reported Disease Activity Correlates With Adverse Pregnancy Outcomes in RA

Patient-Reported Disease Activity Correlates With Adverse Pregnancy Outcomes in RA

By

A clear difference exists in the utility of patient-reported measures of disease activity in women with SLE and those with RA.

Examining the Prevalence, Characteristics of Monophasic Disease Course in SLE

Examining the Prevalence, Characteristics of Monophasic Disease Course in SLE

By

Researchers sought to assess the prevalence and characteristics of monophasic disease course in a defined cohort of patients with SLE.

Comparing Factors Associated With Tubulointerstitial Inflammation in Lupus Nephritis

Comparing Factors Associated With Tubulointerstitial Inflammation in Lupus Nephritis

By

Routinely available serologic markers have no correlation with tubulointerstitial damage in patients with lupus nephritis.

Poverty, Neighborhood May Affect Outcomes in Systemic Lupus Erythematosus

Poverty, Neighborhood May Affect Outcomes in Systemic Lupus Erythematosus

By

Outcomes in systemic lupus erythematosus are largely influenced by level of poverty, type of neighborhood of residence, and chronic stress.

SLE-DAS Superior to SLEDAI-2K in Detecting Changes in SLE Disease Activity

SLE-DAS Superior to SLEDAI-2K in Detecting Changes in SLE Disease Activity

By

To assess validity of SLE-DAS, investigators performed a Spearman's correlation between SLE-DAS, PGA, and SLEDAI-2K at the last follow-up visit.

Cardiac Screening May Not Be Beneficial in SLE With Anti-Ro Antibodies

Cardiac Screening May Not Be Beneficial in SLE With Anti-Ro Antibodies

By

Cardiac screening in patients with systemic lupus erythematosus and anti-Ro-positive antibodies does not appear to be beneficial in clinical practice.

Sign Up for Free e-newsletters